RARX - Ra Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-73,635
-64,943
-54,439
-28,864
-13,943
Depreciation & amortization
1,888
1,597
1,524
1,274
897
Deferred income taxes
-
-
-
-
-
Stock based compensation
10,272
7,695
5,573
1,026
152
Change in working capital
-842
729
555
3,677
285
Accounts receivable
-
-
-
-
64
Inventory
-
-
-
-
-
Accounts Payable
-
-
-
-
-
Other working capital
-63,184
-55,980
-48,191
-26,948
-12,348
Other non-cash items
-
-24
8
1,044
88
Net cash provided by operating activites
-62,292
-54,946
-46,779
-21,843
-12,017
Cash flows from investing activities
Investments in property, plant and equipment
-892
-1,034
-1,412
-5,105
-331
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-
-
-
-
Sales/Maturities of investments
-
-
-
-
-
Other investing activites
-
-
-
129
-1,334
Net cash used for investing activites
-892
-1,034
-1,412
-4,967
-1,664
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
140,532
195,014
0
98,009
-
Common stock repurchased
-
-
0
-22
-193
Dividends Paid
-
-
-
-
-
Other financing activites
-1,162
-377
494
-2,110
4,994
Net cash used privided by (used for) financing activities
141,730
195,421
760
125,236
29,028
Net change in cash
78,546
139,441
-47,431
98,426
15,347
Cash at beginning of period
96,391
71,715
119,146
19,386
4,039
Cash at end of period
174,937
211,156
71,715
117,812
19,386
Free Cash Flow
Operating Cash Flow
-62,292
-54,946
-46,779
-21,843
-12,017
Capital Expenditure
-892
-1,034
-1,412
-5,105
-331
Free Cash Flow
-63,184
-55,980
-48,191
-26,948
-12,348